Imaging Biometics, IQ-AI’s principal investment, recently received a strong endorsement from a leading pharmaceutical company, Bayer AG. The Company’s IB Clinic platform has been chosen to debut in the launch of Bayer’s entrance into artificial intelligence-enabled radiology applications. Bayer’s Calantic platform features only nine products from seven independent companies, which have agreed to partner with […]
Category: IQAI-IQAIF
New Coverage – IQ-AI, Inc. (IQAI: LON, IQAIF: OTCQB)
IQ-AI Ltd. is a holding company investing in technologies based on artificial intelligence (AI). Its principal holding makes it one of the few publicly traded ‘pure plays’ in the fast-growing market for artificial intelligence-enabled medical imaging. Imaging Biometrics (IB) based in Wisconsin provides AI-driven software solutions to hospitals and clinics to improve the quality and […]